GLP-1s Have ‘Wind at Their Back’

Mike Nedelcovych surveys the GLP-1 space after the FDA declared the shortage over, boosting makers like NVO and LLY and hurting compounding pharmacies like HIMS, who will stop offering the drugs. He thinks GLP-1s have the “wind at their back,” but notes that the government may be cracking down on Medicare/Medicaid use of the drugs. However, he says that Medicare expansion would be “icing on the cake.”

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

About Schwab Network - https://schwabnetwork.com/about

Fler avsnitt av Schwab Network